Prestige Wealth Management Group LLC Vertex Pharmaceuticals Inc Transaction History

Prestige Wealth Management Group LLC

$460 Million
Q3 2024

A detailed history of Prestige Wealth Management Group LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 77 shares of VRTX stock, worth $31,429. This represents 0.01% of its overall portfolio holdings.

Number of Shares

Previous 77 -0.0%

Holding current value

$31,429

Previous $36,000 2.78%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$392.81 - $485.53 $5,892 - $7,282	-15 Reduced 16.3%	77 $36,000
Q1 2024 Apr 26, 2024	SELL	$407.69 - $446.08 $4,484 - $4,906	-11 Reduced 10.68%	92 $38,000
Q4 2023 Apr 26, 2024	SELL	$343.0 - $410.68 $2,058 - $2,464	-6 Reduced 5.5%	103 $41,000
Q4 2023 Feb 08, 2024	SELL	$343.0 - $410.68 $2,058 - $2,464	-6 Reduced 5.5%	103 $41,000
Q2 2023 Apr 26, 2024	SELL	$314.42 - $351.91 $1,257 - $1,407	-4 Reduced 3.54%	109 $38,000
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $1,257 - $1,407	-4 Reduced 3.54%	109 $38,000
Q1 2023 Apr 26, 2024	BUY	$283.23 - $323.1 $5,947 - $6,785	21 Added 22.83%	113 $35,000
Q1 2023 May 16, 2023	SELL	$283.23 - $323.1 $1,699 - $1,938	-6 Reduced 5.04%	113 $35,000
Q4 2022 Feb 07, 2023	SELL	$285.76 - $321.48 $206,032 - $231,787	-721 Reduced 85.83%	119 $34,000
Q3 2022 Nov 01, 2022	BUY	$273.83 - $305.53 $174,429 - $194,622	637 Added 313.79%	840 $244,000
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $1,174 - $1,462	-5 Reduced 2.4%	203 $57,000
Q1 2022 May 05, 2022	BUY	$221.42 - $260.97 $442 - $521	2 Added 0.97%	208 $54,000
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $10,089 - $12,736	57 Added 38.26%	206 $46,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $362 - $405	-2 Reduced 1.32%	149 $27,000
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $1,687 - $1,989	-9 Reduced 5.63%	151 $30,000
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $2,484 - $2,895	12 Added 8.11%	160 $34,000
Q4 2020 Feb 17, 2021	SELL	$207.01 - $276.09 $11,799 - $15,737	-57 Reduced 27.8%	148 $35,000
Q3 2020 Oct 26, 2020	BUY	$255.65 - $303.1 $3,323 - $3,940	13 Added 6.77%	205 $55,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $34,272 - $44,961	152 Added 380.0%	192 $55,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $7,990 - $9,912	40 New	40 $10,000
Q4 2019 Jan 28, 2020	SELL	$166.71 - $223.91 $333 - $447	-2 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $332 - $374	2 New	2 $0
Q1 2019 Aug 16, 2019	SELL	$163.73 - $194.7 $20,466 - $24,337	-125 Closed	0 $0
Q4 2018 Apr 16, 2019	BUY	$151.91 - $192.21 $18,988 - $24,026	125 New	125 $21,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.

Account

Prestige Wealth Management Group LLC Vertex Pharmaceuticals Inc Transaction History